RPTX
Repare Therapeutics Inc
$3.15
Earnings Summary
Revenue | $13.05Mn |
Net Profits | $-28.03Mn |
Net Profit Margins | -214.84% |
Highlights
Repare Therapeutics Inc’s revenue fell -28.31% since last year same period to $13.05Mn in the Q4 2023. On a quarterly growth basis, Repare Therapeutics Inc has generated 504.31% jump in its revenue since last 3-months.
Repare Therapeutics Inc’s net profit jumped 11.46% since last year same period to $-28.03Mn in the Q4 2023. On a quarterly growth basis, Repare Therapeutics Inc has generated -48.47% fall in its net profits since last 3-months.
Repare Therapeutics Inc’s net profit margin fell -23.5% since last year same period to -214.84% in the Q4 2023. On a quarterly growth basis, Repare Therapeutics Inc has generated 75.43% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Repare Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.78 |
EPS Estimate Current Year | -0.78 |
Highlights
Repare Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.78 - a -117.58% fall from last quarter’s estimates.
Repare Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.78.
Key Ratios
Key ratios of the Repare Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.67 |
Highlights
Repare Therapeutics Inc’s earning per share (EPS) jumped 10.67% since last year same period to -0.67 in the Q4 2023. This indicates that the Repare Therapeutics Inc has generated 10.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-09 | -0.86 | -0.45 | 47.67% |
2023-05-09 | -0.81 | -0.83 | -2.47% |
2024-02-28 | -0.36 | -0.67 | -86.11% |
2023-08-09 | -0.78 | -0.28 | 64.1% |
₹0 US Stocks a/c Opening Fee